Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Total Current Liabilities (2009 - 2026)

Updated

Alnylam Pharmaceuticals' Total Current Liabilities was $1.51 billion in Q2 2026, up 16.3% from $1.3 billion a year earlier and up 12.1% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Total Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Alnylam Pharmaceuticals came in at $1.47 billion, up 23.6% from FY2024.

  • Total Current Liabilities has now increased for ten consecutive years, with a five-year compound annual growth rate of 20.2% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $1.19 billion in FY2024 (+22.6%), $967.79 million in FY2023 (+26.0%), $767.92 million in FY2022 (+10.4%) and $695.71 million in FY2021 (+18.9%).
  • Quarterly Total Current Liabilities has moved between $605.96 million (Q1 2022) and $1.56 billion (Q3 2025) over five years.
  • Compared with a year earlier, Total Current Liabilities has increased for 41 straight quarters, with growth averaging 22.7% over the last eight quarters.
  • The year-over-year growth in Total Current Liabilities has ranged between 10.4% (Q4 2022) and 39.8% (Q1 2024) over the last five years.
  • Per Business Quant data, ALNY's Total Current Liabilities in the three quarters before Q2 2026 was $1.35 billion (Q1 2026), $1.47 billion (Q4 2025) and $1.56 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 54.90 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 41.64 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -31.55 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 3.94 Bn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn 1.51 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.51 Bn
Mar 31, 2026 1.35 Bn
Dec 31, 2025 1.47 Bn
Sep 30, 2025 1.56 Bn
Jun 30, 2025 1.30 Bn
Mar 31, 2025 1.08 Bn
Dec 31, 2024 1.19 Bn
Sep 30, 2024 1.22 Bn
Jun 30, 2024 1.06 Bn
Mar 31, 2024 941.71 Mn
Dec 31, 2023 967.79 Mn
Sep 30, 2023 949.79 Mn
Jun 30, 2023 788.64 Mn
Mar 31, 2023 673.39 Mn
Dec 31, 2022 767.92 Mn
Sep 30, 2022 772.79 Mn
Jun 30, 2022 657.69 Mn
Mar 31, 2022 605.96 Mn
Dec 31, 2021 695.71 Mn
Sep 30, 2021 610.66 Mn
API Access

Alnylam Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ALNY&period=max&api_key=YOUR_API_KEY